Safety and efficacy of combination of solifenacin with tamsulosin versus tamsulosin alone in patients with benign prostate enlargement and overactive bladder

Trial Profile

Safety and efficacy of combination of solifenacin with tamsulosin versus tamsulosin alone in patients with benign prostate enlargement and overactive bladder

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2016

At a glance

  • Drugs Solifenacin (Primary) ; Tamsulosin
  • Indications Overactive bladder
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Nov 2016 New trial record
    • 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top